PubRank

R L Comis

Author PubWeight™ 58.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer Treat Rep 1976 2.59
2 The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma. Cancer Treat Rev 1975 2.10
3 Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol 1995 1.67
4 The pulmonary toxicity of antineoplastic agents. Semin Oncol 1982 1.65
5 Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results. J Natl Cancer Inst 1992 1.61
6 A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol 1989 1.56
7 Socioeconomic status and cancer survival. J Clin Oncol 1991 1.48
8 Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation. Cancer J Sci Am 2006 1.38
9 Cost effective Internet access and video conferencing for a community cancer network. Proc Annu Symp Comput Appl Med Care 1995 1.28
10 Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res 1991 1.13
11 A review of chemotherapy in gastric cancer. Cancer 1974 1.09
12 Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J Clin Oncol 1996 1.07
13 The implementation of telemedicine within a community cancer network. J Am Med Inform Assoc 1997 1.07
14 Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients. Cancer Res 1979 1.05
15 Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate. Cancer Res 1989 1.01
16 Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma. Cancer Treat Rev 1974 0.98
17 Noncorrelation of the expression of the c-myc oncogene in colorectal carcinoma with recurrence of disease or patient survival. Cancer Res 1988 0.96
18 A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer. Ann Oncol 2009 0.95
19 Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group. Cancer Invest 1992 0.95
20 Small cell carcinoma of the lung. Cancer Treat Rev 1982 0.93
21 Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas. Invest New Drugs 1990 0.92
22 Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer. J Clin Oncol 1990 0.90
23 Phase II trial of extended indications for resection is small cell carcinoma of the lung. J Thorac Cardiovasc Surg 1982 0.88
24 Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors. Cancer 1998 0.88
25 Pharmakokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancer. J Pharmacol Exp Ther 1994 0.85
26 Phase I pharmacokinetic study of intraperitoneal etoposide. Cancer Res 1991 0.84
27 Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease. Clin Immunol Immunopathol 1985 0.84
28 Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon. J Clin Oncol 1990 0.83
29 Gastric cancer: current status of treatment. J Natl Cancer Inst 1977 0.83
30 Abnormalities in water homeostasis in small cell anaplastic lung cancer. Cancer 1980 0.83
31 Bioavailability and pharmacokinetics of etoposide (VP-16). Semin Oncol 1985 0.82
32 A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States. Cancer Res 1982 0.82
33 Mitomycin C in advanced adenocarcinoma and large cell carcinoma of the lung. Cancer Treat Rep 1978 0.82
34 Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes. Cancer Res 1988 0.82
35 Selective surgical resection in small cell carcinoma of the lung. J Thorac Cardiovasc Surg 1979 0.82
36 Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus. Cancer Treat Rep 1977 0.81
37 Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study. J Clin Oncol 1995 0.81
38 Oral etoposide in small-cell lung cancer. Semin Oncol 1986 0.80
39 Biologic effects of gamma interferon pre-treatment followed by monoclonal antibody 17-1A administration in patients with gastrointestinal carcinoma. Hybridoma 1986 0.80
40 Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 study. J Biol Response Mod 1989 0.79
41 The prospect of disease control by surgery combined with chemotherapy in stage I and stage II small cell carcinoma of the lung. Ann Thorac Surg 1983 0.79
42 Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma. Cancer Res 1988 0.79
43 Pharmacologic study of etoposide and cisplatin by the intraperitoneal route. J Clin Pharmacol 1991 0.79
44 Adverse prognostic effect of N2 disease in treated small cell carcinoma of the lung. J Thorac Cardiovasc Surg 1984 0.78
45 Clinical trials of cyclophosphamide, etoposide, and vincristine in the treatment of small-cell lung cancer. Semin Oncol 1986 0.78
46 A phase I study of recombinant interleukin 2 plus recombinant beta-interferon. Cancer Res 1988 0.78
47 Phase II trial of carboplatin in soft-tissue sarcoma. Am J Clin Oncol 1990 0.78
48 Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p. Cancer Res 1987 0.78
49 Treatment of a primary intracranial germ cell tumor with systemic chemotherapy. Med Pediatr Oncol 1981 0.77
50 Mixed germ-cell tumor of the pineal region. Case report. J Neurosurg 1987 0.77
51 Multicenter Phase II trial of etoposide in refractory small cell lung cancer. Cancer Treat Rep 1985 0.77
52 Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approach. Cancer Chemother Pharmacol 1993 0.76
53 Phase I study of sequentially administered recombinant tumor necrosis factor and recombinant interleukin-2. J Immunother Emphasis Tumor Immunol 1995 0.76
54 Long-term survivorship in small-cell anaplastic lung carcinoma. Cancer Treat Rep 1979 0.76
55 Hemorrhagic gastritis as a new dose-limiting toxicity of recombinant tumor necrosis factor. J Natl Cancer Inst 1991 0.76
56 Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide. Br J Cancer 1993 0.75
57 Inverse relationship between constitutive gamma interferon production and human T-cell lymphoma/leukemia virus expression in cultured T lymphocytes. J Virol 1985 0.75
58 Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease. J Clin Oncol 1991 0.75
59 Regional mapping of unique DNA sequences from human chromosome 3 derived from a flow-sorted chromosome library. Cytogenet Cell Genet 1988 0.75
60 Phase I--preliminary phase II trial of iproplatin, a cisplatin analogue. Invest New Drugs 1988 0.75
61 Phase II study of amonafide in advanced and recurrent sarcoma patients. Invest New Drugs 1992 0.75
62 Construction of rare restriction site (NotI, SacII and ClaI) linking libraries and sequence-tagged site analysis of single-copy clones from a human chromosome-3-specific library. Gene 1994 0.75
63 Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. Semin Oncol 1995 0.75
64 Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancer. Eur J Cancer 1991 0.75
65 Available data from carminomycin studies in the United States: the acute intermittent intravenous schedule. Recent Results Cancer Res 1981 0.75
66 Phase II study of amonafide (nafidamide, NSC 308847) in advanced colorectal cancer. Invest New Drugs 1991 0.75
67 Phase 1 and 2 studies of trimetrexate administered in combination with fluorouracil to patients with metastatic cancer. Semin Oncol 1988 0.75
68 Zinostatin and doxorubicin. A combination phase I study. Cancer Clin Trials 1981 0.75
69 Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracil. Cancer Chemother Pharmacol 1989 0.75
70 American experience with carminomycin. Cancer Treat Rep 1979 0.75
71 Phase II study of iproplatin (CHIP) in previously treated small-cell lung cancer. Am J Clin Oncol 1989 0.75
72 Detection of a serum DNA-binding protein associated with cancer. Cancer Res 1982 0.75
73 Cisplatin, bleomycin, and vinblastine combination therapy of testicular tumors: an analysis. Med Pediatr Oncol 1979 0.75
74 Perioperative therapy of non-small cell lung cancer: a review of adjuvant and neoadjuvant approaches. Semin Oncol 1995 0.75
75 Small cell carcinoma of the lung: an overview. Semin Oncol Nurs 1987 0.75
76 Pharmacokinetics of the protein antitumor antibiotic neocarzinostatin after bolus injection in humans. Cancer Res 1979 0.75
77 Assignment of 35 single-copy and 17 repetitive sequence DNA probes to human chromosome 3: high-resolution physical mapping of 7 DNA probes by in situ hybridization. Genomics 1990 0.75
78 Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluation. Am J Clin Oncol 1991 0.75
79 Phase II trials of interferons-alpha and -beta in advanced sarcomas. J Interferon Res 1992 0.75
80 Severe neurotoxicity with methyl G: CALGB experience. Med Pediatr Oncol 1982 0.75
81 Chemotherapy in the treatment of non-small cell lung cancer. Cancer Invest 1986 0.75
82 Unusual cause of increased intracranial pressure from metastatic germ cell cancer. Med Pediatr Oncol 1982 0.75
83 Developing an AHC-MCO alliance for research and care. Health Care Manage Rev 1998 0.75
84 Neocarzinostatin: initial clinical and pharmacologic studies in the United States. Recent Results Cancer Res 1978 0.75
85 Phase I and preliminary phase II study of neocarzinostatin. Cancer Treat Rep 1978 0.75
86 Pharmacokinetic study of trimetrexate in combination with cisplatin. Cancer Res 1991 0.75
87 The development of hyponatremia following combination chemotherapy for metastatic germ cell tumors. Med Pediatr Oncol 1982 0.75
88 Phase II trial of thio-TEPA in relapsed and refractory ovarian carcinoma. Gynecol Oncol 1991 0.75
89 Phase I trial of tallysomycin S10b, a bleomycin analogue. Invest New Drugs 1990 0.75
90 Phase II evaluation of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) in advanced, measurable breast carcinoma. Cancer Invest 1995 0.75
91 Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ). Cancer Treat Rep 1983 0.75
92 Schedule as a determinant of cytotoxic drug activity. Curr Opin Oncol 1989 0.75
93 Pharmacokinetics of carminomycin in dogs and humans. Preliminary report. Cancer Chemother Pharmacol 1981 0.75
94 Small cell carcinoma of the lung: an "updated" overview. Semin Oncol Nurs 1996 0.75
95 The effects of prior exposure to bleomycin on the incidence of pulmonary toxicities in a group of patients with disseminated testicular carcinomas. Med Pediatr Oncol 1978 0.75
96 Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine riboside: optimization of 6-methylmercaptopurine riboside dose and schedule through biochemical analysis of sequential tumor biopsy specimens. J Natl Cancer Inst 1991 0.75
97 Construction of human chromosome-3-specific radiation hybrids and characterization by Alu-PCR. Gene 1994 0.75
98 A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract. Cancer 1989 0.75
99 Phase I trial of 5-fluorouracil, leucovorin, and cisplatin in combination. Cancer Chemother Pharmacol 1990 0.75
100 Zinostatin (neocarzinostatin). Cancer Treat Rev 1979 0.75
101 Small cell anaplastic carcinoma of the lung. The Cancer and Leukemia Group B Experience. Bull Cancer 1982 0.75
102 Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: a Cancer and Leukemia Group B Study. Med Pediatr Oncol 1990 0.75
103 Histologic alterations in small cell carcinoma of the lung after two cycles of intensive chemotherapy. J Thorac Cardiovasc Surg 1984 0.75
104 Vinblastine and inappropriate ADH secretion. N Engl J Med 1977 0.75